ZA200901818B - Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors - Google Patents

Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors

Info

Publication number
ZA200901818B
ZA200901818B ZA200901818A ZA200901818A ZA200901818B ZA 200901818 B ZA200901818 B ZA 200901818B ZA 200901818 A ZA200901818 A ZA 200901818A ZA 200901818 A ZA200901818 A ZA 200901818A ZA 200901818 B ZA200901818 B ZA 200901818B
Authority
ZA
South Africa
Prior art keywords
class
inhibitors
combination
histone
iib
Prior art date
Application number
ZA200901818A
Inventor
Janine Arts
Peter Willem Jan Hellemans
Michel Marie Francois Janicot
Martin John Page
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA200901818B publication Critical patent/ZA200901818B/en

Links

ZA200901818A 2006-09-15 2009-03-13 Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors ZA200901818B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06120726 2006-09-15

Publications (1)

Publication Number Publication Date
ZA200901818B true ZA200901818B (en) 2010-05-26

Family

ID=41040414

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901818A ZA200901818B (en) 2006-09-15 2009-03-13 Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors

Country Status (12)

Country Link
CN (1) CN101516374B (en)
BR (1) BRPI0716992A2 (en)
DK (1) DK2066327T3 (en)
ES (1) ES2399670T3 (en)
ME (1) ME01514B (en)
NZ (1) NZ575030A (en)
PT (1) PT2066327E (en)
RS (1) RS52638B (en)
SG (1) SG177219A1 (en)
SI (1) SI2066327T1 (en)
UA (1) UA97249C2 (en)
ZA (1) ZA200901818B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
CN107095871A (en) * 2016-02-22 2017-08-29 中国科学院上海巴斯德研究所 Quisinostat, a kind of new efficient antimalarial agent
KR20190030693A (en) * 2016-07-20 2019-03-22 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 Histone acetyltransferase activators and compositions and uses thereof
CN114409638B (en) * 2022-02-09 2023-02-14 深圳大学 Histone deacetylase 8 selective degradation agent, preparation method and application thereof in antitumor activity
CN115028678A (en) * 2022-07-08 2022-09-09 杭州医学院 Bifunctional molecule based on BCR-ABL protein degradation induced by VHL ligand and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006010750A1 (en) * 2004-07-28 2006-02-02 Janssen Pharmaceutica N.V. Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase

Also Published As

Publication number Publication date
BRPI0716992A2 (en) 2013-09-17
PT2066327E (en) 2013-02-06
ME01514B (en) 2014-04-20
SI2066327T1 (en) 2013-04-30
SG177219A1 (en) 2012-01-30
CN101516374A (en) 2009-08-26
UA97249C2 (en) 2012-01-25
CN101516374B (en) 2013-04-24
RS52638B (en) 2013-06-28
NZ575030A (en) 2012-07-27
DK2066327T3 (en) 2013-02-11
ES2399670T3 (en) 2013-04-02

Similar Documents

Publication Publication Date Title
HK1136770A1 (en) Histone deacetylase inhibitors with combined activity on class-i and class- iib histone deacetylases in combination with proteasome inhibitors
HK1133199A1 (en) Histone deacetylase and tubulin deacetylase inhibitors
ZA200905060B (en) Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
HK1161583A1 (en) Deacetylase inhibitors and uses thereof
HK1220179A1 (en) Inhibitors of histone deacetylase
EP1973872A4 (en) Inhibitors of histone deacetylase and prodrugs thereof
EP1940805A4 (en) Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
EP1991247A4 (en) Bifunctional histone deacetylase inhibitors
HK1135902A1 (en) Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
EP1991951A4 (en) Portable point of sale systems and methods
IL188692A0 (en) Histone deacetylase inhibitors
EP1945617A4 (en) Histone deacetylase inhibitors with aryl-pyrazolyl motifs
IL193458A0 (en) Histone deacetylase inhibitors
EP1771167A4 (en) Histone deacetylase inhibitors
ZA201002841B (en) Histone deacetylase inhibitors
IL198263A0 (en) Hydroxamates as inhibitors of histone deacetylase
EP1991226A4 (en) Inhibitors of histone deacetylase
EP2308868A4 (en) Histone deacetylase inhibitors and uses thereof
IL214244A (en) Histone deacetylase inhibitors and their use in therapy
EP2208721A4 (en) Histone deacetylase inhibitor, composition and use thereof
EP1784386A4 (en) Histone deacetylase inhibitors
EP2089354A4 (en) Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
EP1784194A4 (en) Histone deacetylase inhibitors
EP2231596A4 (en) Histone deacetylase inhibitors
ZA200901818B (en) Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors